Formulation and evaluation of dorzolamide hydrochloride polymeric film

International Journal of PharmTech Research

Volumn 3, Issue 3, 2011, Pages 1817-1824

  Tandale, Yogyata N ^a   Wagh, Vijay D ^b  

^a KBHSST'S Institute of Pharmacy   (India)

^b Y B CHAVAN COLLEGE OF PHARMACY   (India)

Author keywords

Glaucoma; In vitro release; Transcorneal release studies

Indexed keywords

DORZOLAMIDE; EUDRAGIT; EUDRAGIT RS; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL 400; PLASTICIZER;

ANIMAL EXPERIMENT; ARTICLE; CORNEA PERMEABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; EVAPORATION; FILM; IN VITRO STUDY; INFRARED SPECTROMETRY; LACRIMAL FLUID; NONHUMAN; PH; PHYSICOCHEMICAL MODEL; SURFACE PROPERTY; ULTRAVIOLET SPECTROSCOPY;

EID: 79961130927     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Chien YW. Ocular drug delivery and delivery systems. In: Novel drug delivery systems. 2nd edition. New York: Marcel Dekker; 1992: 269-270.
2. Karthikeyan D., Bhowmick M., Pandey V.P., Nandhakumar J., Sengottuve S., Sonkar, S., Sivakumar T. The concept of ocular inserts as drug delivery systems: An overview. Asian Journal of Pharmaceutics 2008: 460-468.
3. Saettone M.F., Salminen L. Ocular inserts for topical delivery. Advanced Drug Delivery Reviews., 1995, 16: 95-106.
4. Saxena R., Prakash J.,Mathur P.,Gupta S.K. Pharmacotherapy of Glaucoma. Indian Journal of Pharmacology., 2002, 34: 71-85.
5. Resch H., Garhofer G. Topical drug therapy for glaucoma. Wien Med Wochenschr, 2006, 156/17-18: 501-507.
6. nd edition, Churchill Livingstone: D211-D213.
7. Mortimer M.C., Formation of the Aqueous Humor:Transport Components and Their Integration. Current Topics in Membranes 62: 1-45.
8. Michael F.S. Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors. Progress in retinal and eye research 2000, 19(1): 87-112.
9. Gary H., Marilyn H., Glaucoma. Googlesearch.Avialable from http://www. allaboutvision.com. Accessed on 08/03/2009.
10. Lucy Titcomb. An update of Glaucoma. The Pharmaceutical journal 2008: 219-222.
11. Titcomb L. An update of Glaucoma. The Pharmaceutical journal. 2008, 280:219-222.
12. Tanwar Y.S., Patel D., Sisodia S.S. In vitro and in vivo evaluation of ocular inserts of ofloxacin. DARU. 2007, 15(3): 139-145.
13. Yung C. L., Jeffrey W. M., Gerald J. N., Salim I. B., Samuel H. Y. Formulation and in vivo evaluation of ocular insert containing phenylephrine and tropicamide. International Journal of Pharmaceutics 1999, 182: 121-126.
14. Yasmin S., Mohammad A., Asgar A. Ocular inserts for controlled delivery of pefloxacin mesylate: Preparation and evaluation. Acta Pharm., 2005: 305-314.
15. Sadashivaiah R., Dinesh B.M., Patil U.A., Desai B.G., Raghu K.S. Design and in vitro evaluation of haloperidol lactate transdermal patches containing ethyl cellulose-povidone as film formers. Asian journal of Pharmaceutics 2008, 2(1): 43-49.
16. Mishra D.N., Gilhotra R.M. Design and characterization of bioadhesive in-situ gelling ocular inserts of gatifloxacin sesquihydrate. DARU, 2008, 16(1): 1-8.
17. Balasubramaniam J., Srinatha A., Pandit J.K., Nath G. In vitro microbiological evaluation of polyvinyl alcohol-based ocular inserts of Ciprofloxacin hydrochloride. Indian journal of pharmaceutical sciences 2006, 68(5): 626-630.
18. Sofia P., Dimitrios B., Konstantinos A., Evangelos K., Manolis G. Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohydrate Polymers 2008, 73: 44-54.
19. Rao V., Shyale S. Preparation and Evaluation of Ocular Inserts Containing Norfloxacin. Turk J Med Sci. 2004, 34: 239-246.
20. rd edition, 1996: A-117-A-124.
21. Karthikeyan D., Bhowmick M., Pandey V.P., Sengottuvelu S., Sonkar S., Gupta N., Mohod V., Shivakumar T. Design and Evaluation of Ofloxacin Extended Release Ocular Inserts For Once a Day Therapy. Research J. Pharm. and Tech. 2008, 1(4): 460-468.
22. Higuchi, T. Mechanism of sustained-action medication theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963, 52:1145-1149.
23. Peppas N.A. Analysis of Fickian and non-Fickian drug release from polymers.Pharm. Acta Helv. 1985, 60: 110-111.